A new survey has found more than half (52%) of English adults believe that not enough of the NHS budget is being spent on medicines. The survey was commissioned by the Association of the British Pharmaceutical Industry (ABPI), which includes research-based biopharmaceutical companies in the U.K.
The ComRes poll of more than 1,700 adults showed the number rises in older adults, with 60% of adults ages 55 and over believing the NHS’s current 10 cents of every $1 spent on medicines was “not enough,” compared with 40% of adults ages 18 to 24.
About 57% of women and 47% of men polled believe not enough currently is spent on medicines compared with other NHS spending on hospitals, staff and equipment.
This survey comes against the backdrop of a party conference season in which all major parties have promised to make the NHS a priority over the next Parliament despite continued constraints on public spending. The Labor Party and the Liberal Democrats have offered NHS funding increases of more than $1.6 billion, while the Conservatives have said that they will protect the NHS budget in real terms until the next decade.
Access to innovative treatments remains a key issue for voters, and the survey indicates the value in ensuring the right patients get the right choice of medicine, at the right time.
The survey also shows:
ABPI’s 2015 manifesto is calling on the next Parliament to “redouble efforts to boost patients’ access to innovative medicines” under the new Pharmaceutical Price Regulation Scheme (PPRS), in which the biopharmaceutical industry has committed to keep NHS spending on branded medicines flat for two years and under 2% for the following three years.
The manifesto also calls for the government to: